The revolution in cancer therapy began with chemotherapy and radiation, evolved through targeted small molecules, and recently found its zenith in adaptive cell therapies. Today, the focus is decisively shifting towards **innate immunity**, specifically the power of Natural Killer (NK) cells. Unlike T-cells, which require a specific antigen presentation to launch an attack, NK cells possess a...